Podcasts about Uveitis

Efficacy and Safety of Xeligekimab in AS Lessons on Uveitis and AxSpA Difficult to Treat Axial Spondyloarthritis MRI Lesions in Early axSpA vs Non-axSpA Emerging Therapies in Axial Spondyloarthritis Chronic Pain in AxSpA Beyond Fibromyalgia Novel Therapies in Axial Spondyloarthritis GLP 1 Receptor Agonists in axSpA Patients

Deucravacitinib's Place in the PsA Treatment Algorithm? Lessons on Uveitis and AxSpA Difficult to Treat Axial Spondyloarthritis MRI Lesions in Early axSpA vs Non-axSpA JAK Safety Update Why is RA Difficult to Treat? DMARD Combinations in RA Treatment Increased Risk of VTE in RA: Lessons Learned from 40 Years of Data ALTO: Long-term Outcomes of APIPPRA

In this episode, we are joined by pediatric ophthalmologist and uveitis specialist Dr. Ginny Utz and pediatric rheumatologist Dr. Sheila Angeles-Han to discuss a multidisciplinary approach to the management of JIA-associated uveitis.The discussants report no relevant financial disclosures.

Have a red, painful eye that's sensitive to light? Could be uveitis. Hear ophthalmologist Dr. Timothy Janetos discuss uveitis and how it relates to psoriasis and psoriatic arthritis. Join host Takieyah Mathis for an eye opening discussion about uveitis, cataracts, and eye health with ophthalmologist Dr. Timonthy Janetos from Northwestern Medicine, Department of Ophthalmology. Listen as they discuss what is uveitis and cataracts from key symptoms, the significance of the HLA-B27 marker, diagnosis, to treatment options that help reduce inflammation and preserve long term vision. This episode offers information to help you advocate for your eye health by recognizing when you need help from an ophthalmologist and what actions you can take to reduce your risks associated with uveitis. Timestamps: ·       (0:00)          Intro to Psound Bytes & guest welcome ophthalmologist                      Dr. Timothy Milton Janetos. ·       (1:21)          Definition of uveitis and the relationship to psoriatic                            disease. ·       (5:35)          Symptoms of uveitis. ·       (7:45)          How uveitis is diagnosed. ·       (9:24)          Treatment options for uveitis. ·       (13:11)       What happens if eye injections are needed as treatment. ·       (14:47)        Association between inflammation, psoriatic disease,                           and cataracts. ·       (15:48)        Symptoms of a cataract. ·       (16:33)        Treatment for cataracts. ·       (21:11)        New advancements in treating uveitis and cataracts. ·       (25:50)        General eye health actions to help reduce risks                                       associated with inflammation. Early detection is key. 4 Key Takeaways: ·       Uveitis is a huge spectrum of different diseases with about half of the associations due to chronic, immune related diseases like psoriasis or psoriatic arthritis.   ·       If you wake up with a red, painful eye that's sensitive to light, seek help from an ophthalmologist right away to minimize risk of scar tissue formation. ·       Work with a health care team to treat all aspects of psoriatic disease to reduce inflammation whether it's in the skin, joints, and/or the eye. ·       Lifestyle changes such as stop smoking and yearly eye exams are actions that can help reduce inflammatory factors and maintain overall eye health. Guest Bio: Dr. Timothy Milton Janetos is a board-certified and nationally recognized ophthalmologist with Northwestern Medicine, Department of Ophthalmology who specializes in uveitis and cataract surgery.  He is also an Assistant Professor at the Feinberg School of Medicine, Department of Ophthalmology. Dr. Janetos offers comprehensive care using a personalized treatment plan for both children and adults with intraocular inflammation and infections. He is a professional member of the American Uveitis Society (AUS) and the Association for Research in Vision and Ophthalmology (ARVO), as well as the Editor for Frontiers in Ophthalmology and an Editorial Board Member for Annals of Eye Science. Resources: Ø  Psoriatic Arthritis and Uveitis: What's it All About? Podcast with rheumatologist and ophthalmologist Dr. James Rosenbaum. (Released in 2019.)   https://www.psoriasis.org/watch-and-listen/psoriatic-arthritis-and-uveitis-whats-it-all-about-psa/   Ø  Eye Inflammation and Psoriatic Arthritis         https://www.psoriasis.org/advance/eye-inflammation-and- psoriatic-arthritis/  

Have a question you'd like April to answer on the show? Send us a text!"What would you do if your horse was limping, colicking, or spooking—and no one could tell you why?”That question lit a fire in April Love that would grow into a global mission: helping horse owners uncover the root causes of mystery lameness, behavioral issues, and chronic pain that traditional methods often miss.Recently, April joined Kimberley on The Backyard Horse Enthusiast podcast to share her journey, from early passion and endurance riding to developing the revolutionary bodywork system that is now Holistic Horseworks.What makes April's approach unique is that she teaches horse owners how to become their horse's best healer. Through hands-on clinics, online home study courses, and a growing archive of over 200 YouTube videos and bite-sized podcasts, April shares techniques that work—because they're based on real results over decades of experience.From resolving Uveitis without surgery, to transforming behavioral “problem horses” into calm companions, April's stories are more than anecdotes—they're evidence of what's possible when we support the body's ability to heal itself.And the best part? You don't need to be a vet, trainer, or therapist. You just need the right tools, a little guidance—and a deep love for your horse.Thanks to the host Kimberly from The Backyard Horse Enthusiast!Website: https://www.thebackyardhorseenthusiast.com/Youtube: https://www.youtube.com/@UCPzmo1x8mWZWCOmBKIZ9hhw Resources and Products Mentioned in This Episode:Dynamite Release Spray: https://bit.ly/release-sprayHoof, Hand, and Ting Miracle Spray: https://tinyurl.com/miracle-sprayColloidal Silver: https://tinyurl.com/dynamite-solacedoTerra Essential Oils: https://tinyurl.com/hhw-doterraHolistic Horseworks Books: https://amzn.to/4jjyTf7Distance Readings: https://holistichorseworks.com/e4l/Online Home Study Program: https://holistichorseworks.com/best-online-horse-bodywork-course/Horse Yoga: https://tinyurl.com/horse-yoga

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from May 24-30, 2025.

Thirty years ago children with Juvenile Idiopathic Arthritis (JIA) were at high risk of not only crippling physical disability, but also visual loss secondary to cataract, glaucoma and macular oedema caused by their chronic uveitis, or the steroids we used to treat it. Now, thanks to the development of targeted biological therapies, by clinical scientists like Andrew Dick, these children are living normal active lives and their risk of sight loss has been dramatically reduced.In this episode of Eyes on Tomorrow we talk to Andrew about his career-long interest in immunology and inflammatory eye disease and the impact of translational research which has led to a better understanding of cytokine inflammatory pathways in uveitis, the subsequent development of TNF inhibitors and finally landmark trials, like the Sycamore Trial.Andrew stresses the critical importance of working closely with paediatric rheumatologists and of involving patients, no matter how young, in the management of their disease.He has pioneered a “zero-tolerance” approach for the long-term use of topical and systemic steroids, in patients with uveitis, facilitated by the use of biological agents and this has dramatically improved the visual prognosis for patients with uveitis.We also touch upon his clinical approach to new cases of uveitis, his tips for optometrists when confronted by a patient with uveitis and what his passions are away from work.Subscribers to the podcast will have access to the Bonus video episode in which Andrew discusses promising new uveitis treatments, the challenges of managing patients with Gene Therapy Associated Uveitis, his advice to potential budding clinical scientists and his thoughts on leadership.All in all a fantastic listen for anyone who wants to learn more about inflammatory eye disease.Subscribe at eyesontomorrow.substack.com/subscribeProduced by Matt Hill at Rethink Audio. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit eyesontomorrow.substack.com/subscribe

Recurrent uveitis [you-vee-EYE-tus] is a leading cause of blindness in horses. It involves repeated…

Recurrent uveitis [you-vee-EYE-tus] is a leading cause of blindness in horses. It involves repeated inflammation of the uvea [YOU-vee-uh], the pigmented layer of the eye. In cases of equine autoimmune...

Dr. Edmund Tsui interviews authors Dr. Muhammad Z. Chauhan and Dr. Krishna S. Kishor on the risk of uveitis among patients starting topical glaucoma therapy. From their Ophthalmology Glaucoma article, “Incidence of Uveitis Following Initiation of Prostaglandin Analogs versus Other Glaucoma Medications.” Incidence of Uveitis Following Initiation of Prostaglandin Analogs versus Other Glaucoma Medications. Chauhan, Muhammad Z.Amin, Sejal et al. Ophthalmology Glaucoma, Volume 8, Issue 2, 126 – 132.

Prof. Zohar Habot-Wilner (Tel Aviv University) chairs a rich discussion with Prof. Sofia Androudi (University of Thessaly, Greece) and Prof. Sarah Touhami (University of Sorbonne) on managing retinal and uveitic diseases during pregnancy. They explore safe diagnostic tools, therapeutic dilemmas like Ranibizumab vs. Ozurdex, and the effects of pregnancy-related hormonal shifts—highlighting the importance of multidisciplinary collaboration in high-risk cases

Drs. Akshay Thomas and Priya Vakharia join to preview the April 2025 edition of Retinal Physician, focusing on current and future therapies for neovascular AMD.Relevant Financial Disclosures: Dr. Sridhar has consulted for Genentech, Regeneron, and Eyepoint. Dr. Vakharia has consulted for Regeneron, Ocular Therapeutix, and Eyepoint.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

In this episode I break down the latest research on Ozempic and its potential link to NAION (non-arteritic ischemic optic neuropathy), a rare condition that can lead to sudden vision loss. I also reflects on UnitedHealthcare's continued public relations missteps, including its latest legal threats against physicians and anybody on social media, speaking out about the company. Takeaways: The Ozempic and Blindness Connection: Dr. Flannery explains a recent observational study that suggests Ozempic may increase the risk of NAION, a condition that affects the optic nerve. However, the data isn't conclusive yet, and more research is needed before drawing firm conclusions. Uveitis and the Syphilis Conversation: If you have eye inflammation (uveitis), your doctor may need to test for syphilis—leading to some of the most awkward conversations in ophthalmology. Dr. Flannery explains why this is necessary and how it helps with proper diagnosis. UnitedHealthcare's PR Nightmare: The insurance giant recently hired a law firm to threaten doctors on social media, proving once again that they're more focused on silencing criticism than improving patient care. Does Everyone Need Cataract Surgery at 60? Not necessarily! While cataracts affect nearly everyone with age, surgery should only be performed when they significantly impact vision. Dr. Flannery explains how doctors decide when it's time for surgery. Do We Really Need a Spleen? Dr. Flannery debates whether two livers would be better than one liver and a spleen, adding yet another hilarious (but oddly insightful) take on human anatomy. — To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! – http://www.patreon.com/glaucomflecken Also, be sure to check out the newsletter: https://glaucomflecken.com/glauc-to-me/ If you are interested in buying a book from one of our guests, check them all out here: https://www.amazon.com/shop/dr.glaucomflecken If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact. For more information go to Anatomy Warehouse DOT com. Link: Anatomy Warehouse Plus for 15% off use code: Glaucomflecken15 Today's episode is brought to you by DAX Copilot from Microsoft. DAX Copilot is your AI assistant for automating clinical documentation and workflows helping you be more efficient and reduce the administrative burdens that cause us to feel overwhelmed and burnt out. A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit http://www.EyelidCheck.com for more information. Produced by Human Content Learn more about your ad choices. Visit megaphone.fm/adchoices

In this week's episode, our medical student host interviews Dr. JP Dunn, a uveitis specialist at Wills Eye Hospital. He teaches us about uveitis, ocular inflammation, and the delivery of multidisciplinary care within uveitis. After listening to this episode, you will have a better understanding of how to approach a patient presenting to clinic with ocular inflammation and the different conditions seen by a uveitis specialist.

In this OIS Podcast episode, host Dr. Robert Rothman sits down with Daphne Haim-Langford, PhD, Founder & CEO of Tarsier Pharma, and Ashley Kline, Chief Commercial Officer, to discuss their groundbreaking approach to uveitis treatment.Tarsier's lead candidate, TRS01, is a first-in-class bio-inspired therapy designed to control inflammation without raising intraocular pressure, a major complication of steroid treatments. With a unique mechanism of action that modulates macrophages and reduces inflammation, this novel drug has the potential to redefine uveitis and glaucoma care. In this episode, you'll learn:

In the second part of this two-part series, we continue our discussion with Drs. Eric Suhler and George Mount regarding the use of biologics for the management of non-infectious uveitis.Disclosures:Dr. Suhler has consulted for Abbvie

Connect with Taive on Instagram : @taivafinlayson‬ 0:00 Intro 1:10 My diagnosis 3:10 Rheumatoid arthritis 4:35 Growing up 5:30 I was in pain all the time 6:05 Battling Uveitis 8:50 Going blind in one eye 9:00 Uveitis flare up 10:20 Missing out on school activities 12:40 Navigating the condition 13:30 Steroid injection 14:35 Navigating the symptoms 15:40 Support system 16:10 Keep going 17:15 Taking things a lot slower 18:00 It's ok to do things differently 21:15 Being Self conscious 23:00 Calcium buildup 24:10 Laughing it off 25:30 Eye removal 26:50 Living in pain 28:05 London , Ontario 31:20 Taking care of the eye socket 33:00 Eye removal after care 34:15 stitches through my eyelid 35:50 Suction cup 36:00 A conformer 53:34 It was never as bad as I thought it would be

What are the risk factors and frequency of recurrence in patients with acute anterior uveitis? Dr. Edmund Tsui and Dr. Rachael L. Niederer delve into the findings of her recent Ophthalmology study, “Risk of Recurrence in Acute Anterior Uveitis.” Risk of Recurrence in Acute Anterior Uveitis. Brodie, James T. et al. Ophthalmology, Volume 131, Issue 11, 1281 – 1289.

In the first part of this two-part series, we are joined by Drs. Eric Suhler and George Mount to discuss the use of biologics for the management of non-infectious uveitis.Disclosures:Dr. Suhler has consulted for Abbvie

Check out the latest episode of The MOD Pod to hear host Cecelia Koetting, OD, FAAO, Dipl ABO, talk about the use of retinal imaging in hematologic disorders and the diagnosis and treatment of pediatric uveitis with guests Sherrol A. Reynolds, OD, FAAO, FNAP, and Carlo J. Pelino, OD, FAAO, respectively.

La uveítis es una inflamación de la capa media del globo ocular llamada úvea.

In this episode, we are joined by uveitis specialist, Dr. Lyndell Lim and maternal-fetal medicine specialist, Dr. Kelly Kuo to discuss management of uveitis in pregnant patients.The discussants report no relevant financial disclosures.

Psoriasis is not just a skin disease. It's about inflammation. Listen as dermatologist Dr. Chesahna Kindred at Kindred Hair and Skin Center, and moderator Michelle Zimmerman discuss related diseases that people with psoriasis are at risk of developing like uveitis, heart disease, IBD, PsA and more. Hear what screenings and actions you can take to control what you can. For our episode sponsors please check our web page at psoriasis.org/watch-and-listen/. 

In this episode, we are joined by pulmonologist, Dr. Amy Malik and uveitis specialist, Dr. Ananth Sastry to discuss the ocular and systemic considerations in sarcoidosis.The discussant report no relevant financial disclosures.

Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar, and Xenofon Baraliakos to discuss a recent study on the incidence of uveitis in patients with axSpA that were treated with bimekizumab.

Ben Zimmer, CEO of Priovant Therapeutics, focuses on developing therapies for rare autoimmune diseases specifically dermatomyositis, which affects the skin, muscles, and organs, and non-infectious uveitis, a severe ocular inflammatory condition. While these conditions are symptomatically different, mechanistically, they have features in common related to the underlying pathology of the diseases. The drug in development is an oral once-daily therapy that addresses the inflammatory conditions and cytokines driving the pathology. Ben explains, "During COVID, there was a lot of talk about the cytokine storm and these are molecules involved in immune cell signaling. So, they're basically ways that different types of immune cells signal to each other to do different things. There's a large variety of different cytokines and some autoimmune diseases. There are only maybe one or two cytokines or a small number that are driving the pathology of the disease."   "Both dermatomyositis and non-infectious uveitis are highly inflammatory conditions with a lot of different pathogenic cytokines, a lot of different inflammatory axes involved. And so, one of the neat things about our drug, brepocitinib, is that it works on a set category of enzymes called JAKs, and then there are four different types of JAKs, JAK1, JAK2, JAK3, and you might guess JAK4, but it's actually called TYK2. And our drug inhibits TYK2 and JAK1. And by doing that, it suppresses the signaling of a large number of different cytokines." "Uveitis and dermatomyositis have a number of overlapping pathogenic cytokines involved, as well as some different cytokines, but they are both suppressed through the inhibition of TYK2 and JAK1, which our drug does. So, our thesis is to find these highly inflammatory indications, highly inflammatory diseases with high morbidity, which can be expressed in many different organ systems." #PriovantTherapeutics #RareDisease #OrphanIndication #Uveitis #NIU #Dermatomyositis #JAK1 #TYK2 priovanttx.com  Download the transcript here

Ben Zimmer, CEO of Priovant Therapeutics, focuses on developing therapies for rare autoimmune diseases specifically dermatomyositis, which affects the skin, muscles, and organs, and non-infectious uveitis, a severe ocular inflammatory condition. While these conditions are symptomatically different, mechanistically, they have features in common related to the underlying pathology of the diseases. The drug in development is an oral once-daily therapy that addresses the inflammatory conditions and cytokines driving the pathology. Ben explains, "During COVID, there was a lot of talk about the cytokine storm and these are molecules involved in immune cell signaling. So, they're basically ways that different types of immune cells signal to each other to do different things. There's a large variety of different cytokines and some autoimmune diseases. There are only maybe one or two cytokines or a small number that are driving the pathology of the disease."   "Both dermatomyositis and non-infectious uveitis are highly inflammatory conditions with a lot of different pathogenic cytokines, a lot of different inflammatory axes involved. And so, one of the neat things about our drug, brepocitinib, is that it works on a set category of enzymes called JAKs, and then there are four different types of JAKs, JAK1, JAK2, JAK3, and you might guess JAK4, but it's actually called TYK2. And our drug inhibits TYK2 and JAK1. And by doing that, it suppresses the signaling of a large number of different cytokines." "Uveitis and dermatomyositis have a number of overlapping pathogenic cytokines involved, as well as some different cytokines, but they are both suppressed through the inhibition of TYK2 and JAK1, which our drug does. So, our thesis is to find these highly inflammatory indications, highly inflammatory diseases with high morbidity, which can be expressed in many different organ systems." #PriovantTherapeutics #RareDisease #OrphanIndication #Uveitis #NIU #Dermatomyositis #JAK1 #TYK2 priovanttx.com  Listen to the podcast here

What are blepharitis, conjunctivitis, meibomitis, iritis, uveitis, keratitis, retinitis, neuritis, and meningitis? Dr. Cremers reviews eye anatomy and diseases related to the different parts of the eye

Growing up is hard enough but growing up with a chronic condition like juvenile arthritis (JA) has its own set of challenges and unique transitions. In this episode of the Live Yes! With Arthritis podcast, three experts who've lived with JA for a collective 90 years share their experiences. *Visit the Live Yes! With Arthritis Podcast episode page to get show notes, additional resources and read the full transcript: https://arthr.org/LiveYes_Ep108 (https://arthr.org/LiveYes_Ep108) * We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started by emailing podcast@arthritis.org (podcast@arthritis.org). Special Guests: Claire Eby and Matt Allman.

Today, I have a special guest called Peggy joining me to share her story of overcoming the health challenges she faced with her horse Cami.Peggy lives in Alabama. She has two horses, one of which is a 36-year-old Arabian Quarter Horse cross. The other is Cami, a 13-year-old Oldenburg Quarter Horse mare. I began working with Peggy in 2021 when Cami had several challenging health conditions.Initial Contact and Reason for AppointmentAfter hearing me on a podcast, Peggy initially contacted me to help her 36-year-old horse, Sterling, who was struggling with FICO water syndrome. During our discussions, she realized that her other horse, Cami, who was dealing with chronic uveitis, could also benefit from my understanding.Background on CamiPeggy bought Cami in 2020 during the pandemic. She found her online and learned that Cami had only been away from her breeder for about eight months. Initially, she had a stress-free life on 40 acres with a herd, but her next home was stressful. She was kept in a stall 24/7 with little outdoor time and no herd contact, which was a drastic change for her.Initial Health ConcernsWhen Peggy brought Cami home, she knew she had eye issues, and the vet confirmed a minor irritation. Peggy initially managed it with medication, even considering the possibility of removing the eye if necessary. However, as Cami settled in, various other health issues emerged, including weight gain, crusty neck, and anxiety.Treatment and MedicationsPeggy tried multiple medications to manage Cami's eye issues, including oral anti-inflammatories and ointments. Taking her to an ophthalmologist was challenging due to her anxiety around trailering, so Peggy had to manage treatments at home with my help and with that of her vet. It required significant teamwork and research.Initial Attitude and GoalsPeggy was determined to save Cami's eye, feeling that surgery was not a viable option due to her reactive state and the stress it would cause her. She began using positive reinforcement and clicker training to help her administer the medication, which allowed us to manage the symptoms but not solve the underlying problem.Holistic Approach and RealizationsReducing stress and holistically addressing equine health is essential for managing chronic conditions like uveitis. Peggy explains that Cami's health conditions worsened in a less stressful environment as her body began to express the underlying imbalances.Health Deterioration and ProgressPeggy recalls how Cami developed a cataract and went blind in one eye after a severe reaction to annual vaccinations. That led to a visit from an ophthalmologist and required intense medication to save the eye. That period was the beginning of our understanding of how her hypersensitivity led to complex health issues.Managing Multiple Health IssuesCami's immune system was hypersensitive. She reacted to various triggers like vaccinations, ant bites- and even organic fly sprays. Although the increased sensitivity was a sign of her body healing, it also added a layer of complexity to her care.Initial Treatment StrategyMy first treatment program for Cami focused on improving her digestion, regulating her insulin and blood sugar, and reducing oxidative stress rather than directly addressing the eye issue. Peggy began to notice improvements in her overall health, including weight loss, a shinier coat, and healthier hooves.Importance of Detailed ObservationRegular photos helped Peggy monitor changes and effectiveness of treatments and helped her make informed decisions regarding Cami's care. Daily observation and documentation were also required to track her progress.Milestones...

What you need to know about uveitis for your clinical practice and rheumatology board exams.This includes what uveitis actually is, how to think about/classify uveitis in your mind (anatomically; infectious vs non-infectious; systemic vs eye-limited), causes of uveitis, the clinical presentation, workup, management and some extra stuff. As always, "Quiz Time's” are scattered through the episode to check your understanding.Survey link: https://docs.google.com/forms/d/e/1FAIpQLSd6QbrO0kJDzRE8t4fZPIFw1CA9nTw6Qk3Z1FVmCRpt8EdLSg/viewform?usp=sf_link

This week, we are looking at uveitis, sometimes known as moon blindness in horses. Uveitis is a big concern for horse owners because it can lead to blindness and, in severe cases, even result in the horse losing an eye. Even in traditional medicine, the exact cause of this complex and chronic condition remains elusive. So, today, I approach uveitis from a holistic perspective, exploring its various facets and potential treatments.Understanding UveitisUveitis, indicated by the suffix itis, denotes inflammation, specifically chronic inflammation of the uvea, which is one of the layers of the eye. The uvea comprises three structures- the iris, ciliary body, and choroid, which could get damaged in uveitis cases.Possible Causes and Holistic ApproachThe causes of uveitis are diverse and often unknown. A holistic approach considers dietary, lifestyle, and nutritional interventions to reduce inflammation and potentially save the affected eye. Many believe uveitis is triggered by infections or autoimmune responses, leading to continuous inflammation and tissue damage.Genetic PredispositionAppaloosa horses are eight times more likely to develop equine recurrent uveitis, indicating a genetic predisposition. Despite that, horse owners should focus on mitigating the condition with an appropriate diet and lifestyle changes to reduce inflammation and support tissue repair.Stress and ToxicityStress and toxicity are significant triggers for uveitis flare-ups. Stressful events, like separation from the herd or lifestyle changes, can exacerbate the condition. Toxins from medications or vaccinations can also overload the immune system, leading to increased inflammation.Free Radical DamageFree radicals cause considerable damage to tissues, contributing to conditions like uveitis. Antioxidants play a role in neutralizing free radicals, as they protect the tissues from oxidative stress and potential DNA mutations.Connection to Metabolic DisordersHorses with metabolic disorders like insulin resistance or Cushing's disease are more susceptible to uveitis. Those conditions cause chronic inflammation and tissue breakdown, particularly affecting the eyes.Importance of Liver HealthA healthy liver is crucial for eye health, as the liver is responsible for metabolism and detoxification. Supporting liver function through proper diet and supplementation can help reduce the toxic load on the body, protecting the eyes from further damage.Dietary ConsiderationsDietary management is essential, as a diet that minimizes metabolic stress and supports liver function helps to manage the progression of uveitis. It is crucial to eliminate excess sugars, fats, and proteins, as they can exacerbate inflammation and put additional pressure on the liver. Instead, focus on a balanced diet rich in fiber and essential nutrients.Antioxidants and SupplementsThe antioxidants most beneficial for uveitis include zinc, vitamin E, vitamin C, N-acetyl cysteine (NAC), and Coenzyme Q10. Those help reduce inflammation and support overall eye health. However, supplementation should be approached cautiously and tailored to the individual needs of each horse.Homeopathic RemediesHomeopathic remedies like Apis, derived from honeybees, can reduce inflammation and swelling in uveitis cases. However, addressing underlying factors such as stress and metabolic imbalances is also essential.ConclusionManaging uveitis requires a comprehensive approach that includes dietary adjustments and addressing underlying health issues. By reducing inflammation and oxidative stress, owners can improve the outcomes for horses suffering from this chronic...

In this episode, we are joined by Drs. Meghan Berkenstock and Meredith McKean to discuss uveitis secondary to immune checkpoint inhibtor use.

Uveitis is a heterogenous group of inflammatory eye diseases for which current cytokine-targeted immune therapies are effective for only a subset of patients. Dr. Edmund Tsui is joined by Dr. Lynn M. Hassman and MD/PhD student Joseph B. Lin to explore potential common underlying mechanisms that exist for immune cell recruitment in uveitis in their Ophthalmology Science article, “Aqueous macrophages contribute to conserved CCL2 and CXCL10 gradients in uveitis” Aqueous Macrophages Contribute to Conserved CCL2 and CXCL10 Gradients in Uveitis. Lin, Joseph B. et al. Ophthalmology Science, Volume 4, Issue 4. The Ophthalmology-family of journals is now on Instagram. Follow aaojournal for clinical images, research articles, news, editorials, podcasts, and more! Sign up for the next Ophthalmology Journal Virtual Club on June 19, 2024, at https://store.aao.org/ophthalmology-virtual-journal-club.html

Psoriatic arthritis can affect many areas or domains which includes enthesitis, dactylitis, and more. Learn about the PsA domains and how they influence choice of treatments from rheumatologist Dr. Arthur Kavanaugh, Director of the Center for Innovative Therapy in the Division of Rheumatology, Allergy and Immunology at UCSD. This episode is provided with support from Bristol Myers Squibb, AbbVie, Amgen, Johnson & Johnson, Novartis and UCB. 

In this episode, Nicole Scherrer, DVM, Dipl. ACVO, joined us to talk about equine recurrent uveitis (ERU). She discussed clinical signs, management options, and prognoses, and she provided a brief overview of a potential new treatment option that is currently being researched.Disease Du Jour Podcast Hosts, Guests, and Links Episode 133:Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com) Guest: Dr. Nicole Scherrer, DVM, Dipl. ACVOLink: Summary of Dr. Scherrer's AAEP presentation on novel drug SOCS1-KIRPodcast Website: Disease Du JourThe Disease Du Jour podcast is brought to you in 2024 by Merck Animal Health.

In this episode, Nicole Scherrer, DVM, Dipl. ACVO, joined us to talk about equine recurrent uveitis (ERU). She discussed clinical signs, management options, and prognoses, and she provided a brief overview of a potential new treatment option that is currently being researched.Disease Du Jour Podcast Hosts, Guests, and Links Episode 133:Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com) Guest: Dr. Nicole Scherrer, DVM, Dipl. ACVOLink: Summary of Dr. Scherrer's AAEP presentation on novel drug SOCS1-KIRPodcast Website: Disease Du JourThe Disease Du Jour podcast is brought to you in 2024 by Merck Animal Health.

Recent research indicates that those who suffer from AxSpA may have some hope in protecting against events of Uveitis! Dr. Katie Bechman, first author Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics: A Systematic Review and Network Meta-Analysis, explains her team's research findings and how they came to this exciting conclusion! 

Dr. Jack Cush reviews regulatory reports, news and novel journal articles - this week focusing on Sjogrens, ILD, Gout and Uveitis.

Today on Inside GRAPPA, host Fabian Proft is joined by Professor Elaine Husni and Professor Stefan Siebert to discuss the management of conditions related to psoriatic arthritis (PSA), particularly inflammatory bowel disease (IBD) and uveitis. In this episode, we discuss treatment modalities, the importance of early diagnosis, and the implications for clinical practice. The experts also delve into future directions for PSA treatment, highlighting the evolving field of biologics and interdisciplinary approaches. This episode offers a comprehensive exploration of managing associated conditions in PSA, emphasizing the importance of personalized treatment strategies.What's inside this episode?Understanding Psoriatic Arthritis: Insights into managing associated conditions like IBD and uveitis.Expert Discussions: Professors Husni and Siebert share their experiences and approaches in treating these complex cases.Future of Treatment: An overview of emerging therapies and the importance of interdisciplinary collaboration in PSA management.Clinical Perspectives: Exploring the impact of early diagnosis and treatment personalization on patient outcomes.Stay Connected For more intriguing insights and episodes, visit our website. Don't forget to subscribe to Inside GRAPPA for more episodes like this. Share with your colleagues and friends who might benefit from this episode! Hosted on Acast. See acast.com/privacy for more information.

This episode covers anterior uveitis.Written notes can be found at https://zerotofinals.com/medicine/ophthalmology/anterioruveitis/ or in the ophthalmology section of the 2nd edition of the Zero to Finals medicine book.The audio in the episode was expertly edited by Harry Watchman.

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baraliakos to discuss the risk of acute anterior uveitis across different bDMARDs in patients with AS. Our faculty then move on to discuss another publication, which compares patient-reported outcomes (PROs) and 24-month retention rates between patients with axSpA and PsA that were treated with secukinumab.

In this episode of the Thoughtful Entrepreneur, your host Josh Elledge speaks to the Chief Executive Officer of Iroc Marketable Business Solutions, Cori Fonville Foster.Cori's expertise lies in helping her clients maximize their potential by leveraging what they already have. During our conversation, she detailed how her company specializes in providing affordable marketing and sales solutions tailored specifically for coaches and consultants. The key takeaway from Cori's approach is the emphasis on utilizing existing resources and networks. This strategy is cost-effective and ensures that clients are making the most of their current assets.One of Cori's first steps with her clients is conducting a thorough audit of their existing resources. This process involves deep diving into the tools and networks they already have and developing strategies to optimize them. By doing so, clients can avoid the trap of constantly seeking new solutions and instead focus on enhancing what's already working for them.Cori shared compelling examples of how she has guided clients to tap into untapped resources. She recounted stories of clients who had significant, yet underutilized, audiences and networks. By understanding the target audience's preferences and behaviors, Cori helps her clients craft a plan that resonates with their market, increasing engagement and sales.Key Points from the Episode:Introducing Cori Bonneville Foster, CEO of iRoc Marketable Business Solutions.Highlighting Cori's expertise in affordable marketing and sales solutions for coaches and consultants.Focusing on leveraging existing networks and resources for achieving marketing and sales objectives.Showcasing examples of Corey's work with clients and the exploration of untapped opportunities.Detailing Cori's journey from healthcare to entrepreneurship.Prioritizing support for businesses within their first five years.Stressing the value of open and honest discussions with clients to ensure alignment on goals and strategies.About Cori Fonville Foster:Cori Fonville Foster, founder of IROC Marketable Business Solutions, shifted from a medical career due to Uveitis to entrepreneurship. She identified a gap in affordable marketing solutions for small businesses and launched her company, initially offering virtual assistant services. This evolved into a full-service marketing and coaching firm, focusing on strategic planning and practical marketing strategies. Despite personal challenges, her resilience and adaptability have allowed her to support small businesses across the U.S. and internationally. Cori's expertise includes business planning, marketing, and empowerment coaching, making her a valuable resource for entrepreneurs seeking to enhance their business performance. Known for her effective communication and insightful coaching, Cori helps clients achieve their business goals and improve their confidence in the business world.About Iroc Marketable Business Solutions:IROC Marketable Business Solutions is a minority, woman-owned agency that provides budget-conscious marketing solutions to foster business growth. The agency specializes in delivering customized marketing and branding strategies to business owners keen on taking their enterprises to the next level. With a team of seasoned marketing experts, IROC Marketable Business Solutions offers comprehensive support in social media management, website development, email marketing, and business coaching, all tailored to meet its clients' unique needs and aspirations.Tweetable Moments:10:33 - "There is a very...

We discuss the use of an IL-6 inhibitor in the treatment of uveitis macular edema with Dr. Sumit Sharma of the Cole Eye Institute, Cleveland Clinic.

Having both gout and arthritis can be a painful experience, and it's common for individuals to feel helpless, thinking that doing nothing is the only solution. In this episode, Dr. Arinola Dada, board-certified in Internal Medicine, Rheumatology, and Clinical Densitometry, shares her profession and background with us. She dig into how weight impacts joint problems like arthritis, covering topics such as osteoarthritis and gout, the common joints affected by these conditions, triggers for gout attacks (such as certain foods), strategies for improving symptoms (including an anti-inflammatory diet), and the importance of exercise and strengthening for managing arthritis pain. One of her pieces of advice is to start exercising slowly and gradually increase the intensity. She also suggests incorporating low-impact exercises like swimming or using the stairmaster. Don't let pain dictate your life—explore strategies for improvement, from anti-inflammatory diets to gradual exercise. Tune in to the episode and start your journey to a healthier, pain-free lifestyle!   Episode Highlights: Dr. Dada's background How does our weight affect our joint problems Differences between osteoarthritis and gout How to distinguish between osteoarthritis and gout based on the affected joints and the intensity of pain Strategies people should use to be more healthy and improve their symptoms Engaging in low-impact exercises Effectiveness of supplements in treating arthritis Advice for somebody who have osteoarthritis or gout Importance of talking to a doctor for guidance and support Connect with Dr. Arinola Dada: Website | www.drdada.com and www.overlakearthritis.com Facebook | www.facebook.com/arinola.dada Instagram | @dr.arinola_dada Linked In | www.linkedin.com/posts/drarinoladada Youtube | www.youtube.com/@healthyjointshealthylife About Dr. Arinola Dada Dr. Dada was born in Cincinnati Ohio and grew up in Lagos Nigeria, where she received her undergraduate degree and MD degree at the University of Lagos, Nigeria. She returned to the United States and completed her Internal Medicine residency at the Mercy Hospital of Pittsburgh, (now University of Pittsburgh), soon followed by a Fellowship in rheumatology at the University of Washington, Seattle. Dr. Arinola Dada is board certified in Internal Medicine, Rheumatology and Clinical Densitometry. As a practicing rheumatologist since 2001, Dr. Dada wears many hats as a mother, teacher, mentor, and speaker. She was previously a science researcher and later became affiliated with the University of Washington as a clinical instructor in Rheumatology. Her clinical interests include Rheumatoid arthritis, Ankylosing spondylitis, Gout, Psoriatic arthritis, Uveitis, Vasculitis, Myositis, Antiphospholipid Antibodies, Systemic Lupus and Osteoporosis. Dr. Dada is a fellow of the American college of Rheumatology and active in multiple professional organizations including American College of Rheumatology, Washington Rheumatology Alliance, Arthritis Foundation and many others. She has been the recipient of many awards including Top Doc for multiple years in Arthritis today, the National Arthritis foundation ‘my doc rocs' programs as well as multiple years in the Seattle Met magazine. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

For more information, visit https://thecirsgroup.com   CIRS, or Chronic Inflammatory Response Syndrome, is something both Barbara and Jacie have been struggling with for over a year. Since their diagnoses in April of 2022, a lot has happened! Barbara will be sharing her triumphs and setbacks as she now explores endotoxin elimination as the missing piece to healing her gut. Jacie talks about resolving her autoimmune flares, re-exposure while traveling, and how she has reached the final step of the protocol, VIP spray. Spoiler alert: she has already experienced complete symptom resolution with the Shoemaker Protocol! We're excited to share this example of proof that the protocol works. For more information, support, and resources in your own CIRS healing journey, visit TheCIRSGroup.com   TIME STAMPS: 0:00 Intro and disclaimer 1:00 Barbara's CIRS health backstory 2:09 GI issues and MARCoNs persisted, MSH wasn't high enough 3:25 New practitioner, taking the GENIE test 4:58 Endotoxins vs other biotoxins 6:05 Why get the GENIE test, and how to clean for Endos 7:09 Barbara's plan 7:20 Las Vegas is not okay PSA 9:05 Barbara's update wrap up 9:57 Why Barbara is delaying VIP spray 11:45 Jacie's takeaway from Barbara's health journey 12:45 Jacie's CIRS health backstory 13:40 Jacie's biggest lever for healing - removing exposure 15:09 Autoimmune flare: Uveitis, plus travel 16:48 Long COVID or vax injury, spike protein damage protocol 17:59 Jacie's experience with VIP spray (Vasoactive Intestinal Peptide) 19:00 Re-exposure, switching providers, and next steps 21:10 Why NueroQuant may help with VIP treatment 21:34 Resiliency and symptom resolution even before VIP 22:16 Joint and eye damage slowly reversing 25:05 Jacie's mental and physical state in 2022 vs now 26:13 Jacie's takeaway: your body wants to heal 27:19 Genesis 50:20 Barbara's first health update: https://youtu.be/EG5aovrSSYw Jacie's first health update: https://youtu.be/tHeNVVzRyTA Info on the GENIE test: https://www.progenedx.com/ IEP that Barbara used: https://environmentalanalytics.net/ Spike Protein Damage Protocol: https://covid19criticalcare.com/wp-content/uploads/2023/02/I-RECOVER-Post-Vaccine-2023-07-24.pdf   Jacie is a 4 year carnivore, certified nutrition coach, and carnivore recipe developer determined to share the life changing information of carnivore and CIRS to anyone who will listen. Barbara is a coach, facilitator, speaker, 3 year carnivore, and a big fan of health and freedom. Together, they co-founded The CIRS Group, an online support community to help people that are struggling with their CIRS diagnosis and treatment. Catch Jacie and Barbara on Judy Cho's podcast to learn more about their health journeys and why they started The CIRS Group: When Carnivores are Affected by Mold Illness - Jacie Gregory & Barbara Williams - https://youtu.be/CR8Uj-d_fok

Discover the remarkable journey of Dr. Sruthi Arepalli as she conquers the challenges of building a thriving ophthalmology practice specializing in two subspecialties: retina and uveitis.

Our eyes: reflections of the soul, can say more than lips without need of translation and give us a glimpse into stories only a journey can record. Our next guest knows this all too well as he's made a career of looking at rheumatic disease through a different lens. Quite literally. Join us this week for an illuminating discussion with Dr. James T. Rosenbaum, MD, rheumatologist and author of over 650 peer-reviewed manuscripts. Dr. Rosenbaum is credited as being both one of the world's most impactful uveitis scientists for the years 2013 to 2023 and the only practicing rheumatologist to have headed a department of ophthalmology. Dr. Rosenbaum helps us put uveitis into focus this week as we discuss what it is, how he treats it, how to determine if those with it have other rheumatic conditions, and which patients with rheumatic disease should seek additional treatment with an ophthalmologist. 

Drs. Safa Rahmani, Akshay Thomas, and Priya Vakhaira join to discuss the June 2023 issue of Retinal Physician, found online at http://www.retinalphysician.com. Topics covered include the oncology in retina with radiation retinopathy treatment and prevention and newer therapies for choroidal melanoma and retinoblastoma, as well as a uveitis clinical trial review.Relevant Financial Disclosures: None relevantYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Welcome back to our weekend Cabral HouseCall shows! This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track! Check out today's questions:    Heather: Hi, me again! I also had a quick question about the natural flavors listed on the ingredient list for the Daily Fruit and Vegetable powder. What is it? I was under the impression that natural flavors are just another word for artificial flavors but I doubt you would put that in any of your products. Thanks for taking the time to answer our questions!   Amal: Hi Dr Cabral, I've been diagnosed with an inflammatory eye condition called Uveitis in my left eye. Doctors have not looked into what's causing it but I think it is autoimmune. I also seem to have something called lipedema. Everytime I try to detox my body, it will accelerate the inflammation in my eye, causing further damage to the eye. I tried to take iodine and it would help my eye but cause me to rapid fat gain everywhere. I then tried N acetyl cysteine and the same rapid weight gain but it would lower inflammation in the eye and clear my vision. Then I tried chlorella and spirulina and I would feel coolness in my eyes in 10 mins and it would clear my floaters, inflammation and improve vision. However I will gain a lot of body fat within 2 days of taking the chlorella & spirulina. I came across gynostemma herbal tea and I started losing weight within days but my eye would start hurting and I could also feel weakness in my right eye. I'm not sure what to do. I cant lose the weight without hurting my eye and I can't detox my liver or the rest of my body without gaining weight. My hair has become damaged and dry and I have developed a lot of cellulite on my legs and excess fat around my ankles and everywhere else. I am trying to work on gut health Any advice would be helpful.    Alicja: Hi Dr. Cabral, I would love to get your opinion about inducing period with prescription drugs. I lost my periods a while ago, but I'm only 38 so probably too early to be menopausal. 4 years ago I was pregnant and then was breastfeeding my baby for a while. It's been about 2 years since I stopped breastfeeding, but my cycles don't want to return. After having my baby I developed gut issues. Later I also found out I have hypothyroidism and Hashimoto. I've been addressing both. Overall I feel now much better and stronger comparing to where I was a year ago (thanks to moving to a new house and thanks to your protocols. I've done para pro and currently I'm in the muddle of CBO protocol) I should mention that I am underweight (BMI: 16.2) Since I've been feeling better recently, do you think I could now "induce" my period with a medication? Or do you think I should still wait longer until my body decides it's time. I'm not sure if it's good for me to be that long without cycles. I often hear from other women that once first period is induced, next ones come on their own. I tried Vitex in the past but stopped because I didn't feel well taking it. Thank you so much for your answer. I'm forever thankful for all your help.    Paula: Can you do a podcast on adolescent sports medicine or adolescent sports nutrition? Thanks.   Lynn: Hi Dr. Cabral, I've enjoyed your podcast for years now, thank you for such great content. Recently I was diagnosed with posterior vitreous detachment by my optometrist. What would you suggest? Thank you so much Lynn    Zak: Hi Dr. Cabral, I have been looking at taking NMN together with Trans Resveratrol however am concerned about any implications these 2 supplements may have on Hashimotos which I have. I have read a pubmed study suggesting that TSH may increase and that NMN is an antagonist to thyroid hormones? I would love to take NMN for all the benefits mentioned in your previous podcast however have reservations. Are you a able to shed some light on the effects NMN may have on the thyroid in particular Hashimotos? Thanks so much for all your insightful material. Zak   Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!    - - - Show Notes and Resources: StephenCabral.com/2493 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!